Your browser doesn't support javascript.
loading
Understanding the Treatment Algorithm of Patients with Metastatic Pancreatic Neuroendocrine Neoplasms: A Single-Institution Retrospective Analysis Comparing Outcomes of Chemotherapy, Molecular Targeted Therapy, and Peptide Receptor Radionuclide Therapy in 255 Patients.
Hayes, Aimee R; Mak, Ingrid Y F; Evans, Nicholas; Naik, Rishi; Crawford, Alexander; Khoo, Bernard; Grossman, Ashley B; Navalkissoor, Shaunak; Watkins, Jennifer; Luong, Tu Vinh; Mandair, Dalvinder; Toumpanakis, Christos; Thirlwell, Christina; Caplin, Martyn E; Meyer, Tim.
Afiliação
  • Hayes AR; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom, aimeehayes@hotmail.com.
  • Mak IYF; Department of Oncology, Royal Free Hospital, London, United Kingdom, aimeehayes@hotmail.com.
  • Evans N; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom.
  • Naik R; Medical School, University College London, London, United Kingdom.
  • Crawford A; Medical School, University College London, London, United Kingdom.
  • Khoo B; Medical School, University College London, London, United Kingdom.
  • Grossman AB; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom.
  • Navalkissoor S; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom.
  • Watkins J; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom.
  • Luong TV; Department of Nuclear Medicine, Royal Free Hospital, London, United Kingdom.
  • Mandair D; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom.
  • Toumpanakis C; Department of Cellular Pathology, Royal Free Hospital, London, United Kingdom.
  • Thirlwell C; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom.
  • Caplin ME; Department of Cellular Pathology, Royal Free Hospital, London, United Kingdom.
  • Meyer T; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom.
Neuroendocrinology ; 111(9): 863-875, 2021.
Article em En | MEDLINE | ID: mdl-32950978
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Radioterapia / Algoritmos / Avaliação de Resultados em Cuidados de Saúde / Tumores Neuroendócrinos / Terapia de Alvo Molecular / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Radioterapia / Algoritmos / Avaliação de Resultados em Cuidados de Saúde / Tumores Neuroendócrinos / Terapia de Alvo Molecular / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article